Jonathan R. Rumble

905 total citations
17 papers, 753 citations indexed

About

Jonathan R. Rumble is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Clinical Biochemistry. According to data from OpenAlex, Jonathan R. Rumble has authored 17 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 8 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Clinical Biochemistry. Recurrent topics in Jonathan R. Rumble's work include Diabetes Treatment and Management (5 papers), Renin-Angiotensin System Studies (4 papers) and Advanced Glycation End Products research (4 papers). Jonathan R. Rumble is often cited by papers focused on Diabetes Treatment and Management (5 papers), Renin-Angiotensin System Studies (4 papers) and Advanced Glycation End Products research (4 papers). Jonathan R. Rumble collaborates with scholars based in Australia, United States and Germany. Jonathan R. Rumble's co-authors include Richard E. Gilbert, Mark E. Cooper, Alison J. Cox, Darren J. Kelly, George Jerums, M. E. Cooper, Radko Komers, Sherif Youssef, Tina Soulis and Adrienne D. Cox and has published in prestigious journals such as Journal of Clinical Investigation, Circulation Research and Diabetes.

In The Last Decade

Jonathan R. Rumble

17 papers receiving 736 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan R. Rumble Australia 11 269 167 153 152 135 17 753
Bishoy Rizkalla Australia 8 166 0.6× 147 0.9× 69 0.5× 304 2.0× 152 1.1× 15 891
M Maiello Italy 14 96 0.4× 100 0.6× 98 0.6× 234 1.5× 148 1.1× 24 817
Sherif Youssef Australia 8 207 0.8× 231 1.4× 118 0.8× 265 1.7× 325 2.4× 14 963
D Boeri Italy 11 100 0.4× 90 0.5× 88 0.6× 191 1.3× 137 1.0× 13 669
Katsuhiko Takenaka Japan 16 166 0.6× 253 1.5× 109 0.7× 263 1.7× 467 3.5× 28 1.0k
Minori Mizoguchi Japan 10 291 1.1× 162 1.0× 189 1.2× 149 1.0× 152 1.1× 11 823
Masaki Togawa Japan 17 237 0.9× 161 1.0× 133 0.9× 471 3.1× 160 1.2× 33 1.2k
Joon Keun Park Germany 7 147 0.5× 96 0.6× 70 0.5× 217 1.4× 27 0.2× 7 637
Nahid Alavi United States 9 200 0.7× 165 1.0× 49 0.3× 147 1.0× 76 0.6× 13 582
Joseph W. Covington United States 11 143 0.5× 135 0.8× 173 1.1× 363 2.4× 27 0.2× 14 930

Countries citing papers authored by Jonathan R. Rumble

Since Specialization
Citations

This map shows the geographic impact of Jonathan R. Rumble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan R. Rumble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan R. Rumble more than expected).

Fields of papers citing papers by Jonathan R. Rumble

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan R. Rumble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan R. Rumble. The network helps show where Jonathan R. Rumble may publish in the future.

Co-authorship network of co-authors of Jonathan R. Rumble

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan R. Rumble. A scholar is included among the top collaborators of Jonathan R. Rumble based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan R. Rumble. Jonathan R. Rumble is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Paizis, G., Richard E. Gilbert, Mark E. Cooper, et al.. (2001). Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis. Journal of Hepatology. 35(3). 376–385. 129 indexed citations
2.
Jandeleit‐Dahm, Karin, Jonathan R. Rumble, Alison J. Cox, et al.. (2000). SPARC Gene Expression Is Increased in Diabetes-Related Mesenteric Vascular Hypertrophy. Microvascular Research. 59(1). 61–71. 13 indexed citations
3.
Gilbert, Richard E., Darren J. Kelly, Alison J. Cox, et al.. (2000). Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes. Diabetologia. 43(11). 1360–1367. 151 indexed citations
4.
Gilbert, Richard E., Jonathan R. Rumble, Zemin Cao, et al.. (2000). Endothelin Receptor Antagonism Ameliorates Mast Cell Infiltration, Vascular Hypertrophy, and Epidermal Growth Factor Expression in Experimental Diabetes. Circulation Research. 86(2). 158–165. 64 indexed citations
5.
Rumble, Jonathan R., Richard E. Gilbert, Alison J. Cox, Leonard L. Wu, & Mark E. Cooper. (1998). Angiotensin converting enzyme inhibition reduces the expression of transforming growth factor-β1 and type IV collagen in diabetic vasculopathy. Journal of Hypertension. 16(11). 1603–1609. 26 indexed citations
6.
Cooper, Mark E., Zemin Cao, Jonathan R. Rumble, et al.. (1998). Attenuation of diabetes-associated mesenteric vascular hypertrophy with perindopril: Morphological and molecular biological studies. Metabolism. 47(12 Suppl 1). 24–27. 16 indexed citations
7.
Rumble, Jonathan R., M. E. Cooper, Tina Soulis, et al.. (1997). Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products.. Journal of Clinical Investigation. 99(5). 1016–1027. 160 indexed citations
8.
Rumble, Jonathan R., Radko Komers, & Mark E. Cooper. (1996). Kinins or nitric oxide, or both, are involved in the antitrophic effects of angiotensin converting enzyme inhibitors on diabetes-associated mesenteric vascular hypertrophy in the rat. Journal of Hypertension. 14(5). 601–607. 29 indexed citations
9.
Cooper, Mark E., Dimitria Vranes, & Jonathan R. Rumble. (1996). Diabetic Vascular Injury and ACE. Drugs & Aging. 8(1). 38–46. 2 indexed citations
10.
Allen, Terri J., et al.. (1995). Diabetic vascular hypertrophy and albuminuria: Effect of angiotensin converting enzyme inhibition. Journal of Diabetes and its Complications. 9(4). 318–322. 5 indexed citations
11.
Rumble, Jonathan R., Adam Doyle, & Matthew A. Cooper. (1995). Comparison of effects of ACE inhibition with calcium channel blockade on renal disease in a model combining genetic hypertension and diabetes. American Journal of Hypertension. 8(1). 53–57. 29 indexed citations
12.
Rumble, Jonathan R., et al.. (1995). Vascular albumin permeability and hypertrophy in a rat model combining streptozotocin-induced diabetes and genetic hypertension. Journal of Hypertension. 13(5). 529–533. 7 indexed citations
13.
Cooper, M. E., et al.. (1994). Diabetes-associated mesenteric vascular hypertrophy is attenuated by angiotensin-converting enzyme inhibition. Diabetes. 43(10). 1221–1228. 30 indexed citations
14.
Bach, Leon A., Mark E. Cooper, Dimitria Vranes, et al.. (1994). Disparate effects of castration on renal structure and function in the streptozotocin diabetic rat.. PubMed. 27(1). 27–38. 5 indexed citations
15.
Cooper, Mark E., et al.. (1994). Diabetes-Associated Mesenteric Vascular Hypertrophy Is Attenuated by Angiotensin-Converting Enzyme Inhibition. Diabetes. 43(10). 1221–1228. 72 indexed citations
16.
Cooper, Mark E., et al.. (1992). DIABETIC RENAL MICROVASCULAR DISEASE: THE ROLE OF HYPERTENSION AND ACE INHIBITORS. Clinical and Experimental Pharmacology and Physiology. 19(S19). 23–27. 9 indexed citations
17.
Rumble, Jonathan R., et al.. (1990). Database Systems in Science and Engineering. CERN Document Server (European Organization for Nuclear Research). 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026